TY - JOUR
T1 - A randomised controlled trial of hearing and vision support in dementia
T2 - Protocol for a process evaluation in the SENSE-Cog trial
AU - Leroi, Iracema
AU - Armitage, Christopher J.
AU - Collin, Fidéline
AU - Frison, Eric
AU - Hann, Mark
AU - Hooper, Emma
AU - Reeves, David
AU - Simkin, Zoe
AU - Wolski, Lucas
AU - Abrams, Harvey
AU - Chaghil-Boissière, Nathalie
AU - Charalambous, Anna Pavlina
AU - Collin, Fidéline
AU - Constantinidou, Fofi
AU - Crosby, Lisa
AU - Dawes, Piers
AU - Gilbert, Camille
AU - Hann, Mark
AU - Hooper, Emma
AU - Himmelsbach, Ines
AU - Kontogianni, Evangelia
AU - Lawlor, Brian
AU - Leroi, Iracema
AU - Marie, Sarah
AU - Montecelo, Susana
AU - Politis, Antonios
AU - Postea, Otilia
AU - Reeves, David
AU - Renaud, David
AU - Simkin, Zoe
AU - Termote, Monique
AU - Thodi, Chryssoula
AU - Wolski, Lucas
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/2/24
Y1 - 2020/2/24
N2 - Background: Optimising hearing and vision function may be important in improving a range of outcomes for people living with dementia (PwD) and their companions. The SENSE-Cog cross-national randomised controlled trial (RCT) is evaluating the effectiveness of a sensory intervention (SI) to improve quality of life for PwD with concurrent hearing and/or vision impairment, in five European countries. To ascertain how or why the intervention will, or will not, achieve its outcomes, we have designed a process evaluation to explore potential discrepancies between expected and observed outcomes. This will also help us to understand how context may influence the outcomes. Here we describe the protocol for this process evaluation, which is embedded within the RCT. Methods/design: We will use a mixed methods approach with a theoretical framework derived from the UK Medical Research Council's' guidance on process evaluations. It will include the following: (1) evaluating how key aspects of the intervention will be delivered, which will be important to scale the intervention in real world populations; (2) characterising the contextual issues, which may shape the delivery and the impact of the intervention in different countries; and (3) investigating possible causal mechanisms through analyses of potential moderators and mediators. To avoid bias, we will analyse the process data before the analysis of the main effectiveness outcomes. Discussion: This evaluation will provide insight into how the complex SENSE-Cog SI will be tailored, enacted and received across the different European contexts, all of which have unique health and social care economies. The findings will provide insight into the causal mechanisms effecting change, and will determine whether we should implement the intervention, if effective, on a wider scale for PwD and concurrent sensory impairment.
AB - Background: Optimising hearing and vision function may be important in improving a range of outcomes for people living with dementia (PwD) and their companions. The SENSE-Cog cross-national randomised controlled trial (RCT) is evaluating the effectiveness of a sensory intervention (SI) to improve quality of life for PwD with concurrent hearing and/or vision impairment, in five European countries. To ascertain how or why the intervention will, or will not, achieve its outcomes, we have designed a process evaluation to explore potential discrepancies between expected and observed outcomes. This will also help us to understand how context may influence the outcomes. Here we describe the protocol for this process evaluation, which is embedded within the RCT. Methods/design: We will use a mixed methods approach with a theoretical framework derived from the UK Medical Research Council's' guidance on process evaluations. It will include the following: (1) evaluating how key aspects of the intervention will be delivered, which will be important to scale the intervention in real world populations; (2) characterising the contextual issues, which may shape the delivery and the impact of the intervention in different countries; and (3) investigating possible causal mechanisms through analyses of potential moderators and mediators. To avoid bias, we will analyse the process data before the analysis of the main effectiveness outcomes. Discussion: This evaluation will provide insight into how the complex SENSE-Cog SI will be tailored, enacted and received across the different European contexts, all of which have unique health and social care economies. The findings will provide insight into the causal mechanisms effecting change, and will determine whether we should implement the intervention, if effective, on a wider scale for PwD and concurrent sensory impairment.
KW - Complex intervention
KW - Dementia
KW - Hearing impairment
KW - Logic model
KW - Mediators
KW - Moderators
KW - Process evaluation
KW - Randomised controlled trial
KW - Sensory impairment
KW - Vision impairment
UR - https://www.scopus.com/pages/publications/85079910475
U2 - 10.1186/s13063-020-4135-4
DO - 10.1186/s13063-020-4135-4
M3 - Article
C2 - 32093757
AN - SCOPUS:85079910475
SN - 1745-6215
VL - 21
JO - Trials
JF - Trials
IS - 1
M1 - 223
ER -